SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0104 Estimated average burden hours per response: 0.5

1. Name and Address of Reporting Person* Conger Daniel E (Last) (First) (Middle) C/O SEMLER SCIENTIFIC, INC. 2330 NW EVERETT ST. (Street) PORTLAND OR 97210 (City) (State) (Zip)	2. Date of Event Requiring Statement (Month/Day/Year) 02/18/2016	3. Issuer Name and Ticker or Trading Symbol Semler Scientific, Inc. [ SMLR ]
		4. Relationship of Reporting Person(s) to Issuer (Check all applicable) Director 10% Owner X Officer (give title below) Other (specify below) Vice President, Finance	5. If Amendment, Date of Original Filed (Month/Day/Year)
			6. Individual or Joint/Group Filing (Check Applicable Line) X Form filed by One Reporting Person Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (right to buy)	11/01/2010(1)	11/01/2020	Common Stock	6,500	0.52	D
Stock Option (right to buy)	06/10/2011(1)	06/10/2021	Common Stock	6,500	0.52	D
Stock Option (right to buy)	01/05/2012(1)	01/05/2022	Common Stock	6,500	0.52	D
Stock Option (right to buy)	11/21/2012(1)	11/21/2022	Common Stock	10,000	0.52	D
Stock Option (right to buy)	11/08/2014(2)	11/08/2024	Common Stock	5,000	2.1	D
Stock Option (right to buy)	10/29/2015(2)	10/29/2025	Common Stock	10,000	3.44	D
Stock Option (right to buy)	12/31/2015(2)	12/31/2025	Common Stock	10,000	2.59	D

Explanation of Responses:

1. These options were granted pursuant to the Issuer's 2007 Key Person Stock Option Plan and are fully vested.

2. These options were granted pursuant to the Issuer's 2014 Stock Incentive Plan and are subject to monthly vesting over four years (1/48 per month) such that they will be vested in full on the four-year anniversary of their respective grant dates.

	/s/ Daniel E. Conger	02/22/2016
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.